GO:0033306 phytol metabolic process: Lipid Metabolism Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0033306 phytol metabolic process describes the chemical reactions and pathways involving phytol, a branched-chain unsaturated fatty alcohol derived from chlorophyll.
Phytol metabolism is best characterized in plants, where it is released from chlorophyll and converted to phytanic acid, which is then subject to alpha-oxidation.
In mammals, phytol is a dietary precursor of phytanic acid, and its accumulation is linked to Refsum disease and other peroxisomal disorders.
Key enzymes include phytol kinase, phytol dehydrogenase, and phytanoyl-CoA hydroxylase, which act in sequence to modify and activate phytol.
Phytol and its metabolites have documented biomedical activities, including antioxidant, anti-inflammatory, and anticancer effects in preclinical models.
Dysregulation of fat-soluble vitamin and phytol-related metabolic processes has been associated with glioma progression, highlighting clinical relevance.

Description

Phytol metabolic process (GO:0033306) is the set of biochemical reactions and pathways that transform phytol, a long-chain unsaturated fatty alcohol, into other metabolites. Phytol is best known as the hydrophobic side chain of chlorophyll, and its release during chlorophyll breakdown makes it an abundant lipid substrate in plants and in the diet of herbivores and humans. The term encompasses both the initial oxidation and phosphorylation of phytol and its downstream conversion to phytanic acid and related products. Because phytol is a fat-soluble molecule, its metabolism intersects with vitamin K and vitamin E pathways and with peroxisomal fatty acid oxidation. Researchers study this process to understand plant lipid remodeling, human peroxisomal disease, and the pharmacological potential of phytol-derived compounds. The QuickGO definition provides a precise scope: the chemical reactions and pathways involving phytol, (2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol. This article integrates the QuickGO definition with verified PubMed literature to describe the mechanism, key genes, disease links, and experimental models for GO:0033306.

phytol metabolic process At A Glance

GO ID GO:0033306
GO term phytol metabolic process
Ontology biological_process
Synonym phytol metabolism
Definition The chemical reactions and pathways involving phytol, (2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol.
Major function Conversion of phytol to phytanic acid and related metabolites, including phosphorylation and oxidation steps.
Related pathways Chlorophyll degradation, peroxisomal alpha-oxidation, fat-soluble vitamin metabolism.
Key enzymes Phytol kinase, phytol dehydrogenase, phytanoyl-CoA hydroxylase.
Disease relevance Refsum disease, peroxisomal disorders, glioma progression.

What Is GO:0033306?

GO:0033306 phytol metabolic process is defined by QuickGO as the chemical reactions and pathways involving phytol, (2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol. In practice, this includes the enzymatic oxidation, phosphorylation, and activation of phytol, its conversion to phytanic acid, and the subsequent alpha-oxidation or other transformations of phytol-derived intermediates. The term is a biological process and is distinct from chlorophyll catabolism, although phytol release often accompanies chlorophyll breakdown.

Why Is phytol metabolic process Important in Cell Biology?

Phytol metabolic process is important because phytol is one of the most abundant acyclic diterpene alcohols in nature and a major dietary lipid. In plants, phytol metabolism is essential for recycling chlorophyll-derived lipids and for producing phytanic acid, which can influence membrane properties and signaling. In humans, inherited defects in phytol and phytanic acid metabolism cause Refsum disease and related peroxisomal disorders, making this pathway clinically significant. Moreover, phytol and its derivatives exhibit antioxidant, anti-inflammatory, and anticancer activities in preclinical studies, suggesting therapeutic potential. Recent work has also linked fat-soluble vitamin metabolic processes, including phytol-related pathways, to glioma progression. Thus, GO:0033306 is a nexus for plant biochemistry, human genetics, and pharmacology.
Phytol is a major component of chlorophyll and a dietary lipid, making its metabolism central to plant and animal lipid homeostasis.
Phytol is converted to phytanic acid, a branched-chain fatty acid that cannot undergo beta-oxidation and requires alpha-oxidation.
Defects in phytanic acid metabolism cause Refsum disease, a neurological disorder characterized by phytanic acid accumulation.
Phytol metabolism intersects with fat-soluble vitamin pathways, including vitamin K and vitamin E.
Phytol and its metabolites show antioxidant and anti-inflammatory activities in biomedical research.
Phytol-derived compounds are studied for anticancer effects in various cell and animal models.
Fat-soluble vitamin metabolic processes, including phytol-related pathways, have been associated with glioma progression.
Microbial strain engineering can upgrade phytol-related fermentation processes for industrial applications.
Drug-nutrient interactions can influence phytol and fat-soluble vitamin metabolism, affecting therapeutic outcomes.
Phytol metabolism is a model for studying peroxisomal alpha-oxidation and lipid remodeling in plants.

What Happens During phytol metabolic process?

Release of phytol from chlorophyll
In simple terms: Phytol is first freed from chlorophyll before it can be metabolized.
Phytol is esterified to chlorophyll a and b, and during chlorophyll breakdown, phytol is released by chlorophyllase and related hydrolases. This step makes phytol available for subsequent enzymatic conversions. In plants, the release of phytol is tightly linked to senescence and chloroplast dismantling.
Phosphorylation of phytol to phytyl phosphate
In simple terms: Phytol gets a phosphate group added, making it more reactive.
Phytol kinase catalyzes the ATP-dependent phosphorylation of phytol to phytyl phosphate, a key intermediate in phytol metabolism. This phosphorylation activates phytol for further transformations, including conversion to phytyl diphosphate, which can be used for tocopherol and chlorophyll synthesis.
Oxidation of phytol to phytanal and phytenic acid
In simple terms: Phytol is oxidized stepwise to produce phytanal and then phytenic acid.
Phytol dehydrogenase and related oxidoreductases convert phytol to phytanal, which is further oxidized to phytenic acid. These oxidation steps are part of the pathway that ultimately leads to phytanic acid. In mammals, phytol can also be oxidized to phytanic acid via intermediates.
Conversion to phytanic acid and alpha-oxidation
In simple terms: Phytanic acid is formed and then broken down by alpha-oxidation because it cannot be beta-oxidized.
Phytenic acid is reduced to phytanic acid, which then undergoes alpha-oxidation in peroxisomes. Phytanoyl-CoA hydroxylase (PHYH) catalyzes the first step of alpha-oxidation, and defects in this enzyme cause Refsum disease. This step is essential for degrading branched-chain fatty acids and preventing their accumulation.
Regulation and integration with other lipid pathways
In simple terms: Phytol metabolism is controlled by enzyme levels and linked to vitamin and lipid pathways.
The flux through phytol metabolism is regulated by the expression and activity of phytol kinase, phytol dehydrogenase, and alpha-oxidation enzymes. It is also integrated with fat-soluble vitamin metabolism, including vitamin K and vitamin E pathways. In plants, phytol metabolism is coordinated with chlorophyll synthesis and degradation during development and stress.

Key Genes Involved in GO:0033306 phytol metabolic process

The following genes and proteins are experimentally implicated in phytol metabolic process and its related pathways, based on the verified literature.
GeneMajor RoleResearch Relevance
PHYHPhytanoyl-CoA hydroxylase, catalyzes alpha-oxidation of phytanic acidMutations cause Refsum disease; target for peroxisomal disorder research
PHYKPhytol kinase, phosphorylates phytol to phytyl phosphateKey enzyme in phytol activation; studied in plants and microbes
ADHAlcohol dehydrogenase, oxidizes phytol to phytanalInvolved in phytol oxidation; potential target for metabolic engineering
ALDHAldehyde dehydrogenase, oxidizes phytanal to phytenic acidContributes to phytol catabolism; studied in lipid metabolism
PEX7Peroxisomal targeting signal 2 receptorRequired for import of PHYH into peroxisomes; defects cause Refsum disease
PEX5Peroxisomal targeting signal 1 receptorInvolved in peroxisomal import of alpha-oxidation enzymes
VKORC1Vitamin K epoxide reductase, involved in vitamin K cycleLinks phytol metabolism to fat-soluble vitamin pathways
TTPAAlpha-tocopherol transfer proteinRegulates vitamin E levels; interacts with phytol-derived lipids
CYP4FCytochrome P450 family, oxidizes fatty acidsMay contribute to phytol and phytanic acid oxidation
ACOXAcyl-CoA oxidase, peroxisomal beta-oxidationRelated to fatty acid oxidation pathways intersecting with phytol
HACL12-hydroxyacyl-CoA lyase, involved in alpha-oxidationParticipates in phytanic acid breakdown
SCPxSterol carrier protein X, thiolase in peroxisomesInvolved in branched-chain fatty acid metabolism
GGPS1Geranylgeranyl diphosphate synthaseRelated to phytol-derived isoprenoid pathways
VTE1Tocopherol cyclase, uses phytyl diphosphateLinks phytol metabolism to vitamin E synthesis
HPPD4-hydroxyphenylpyruvate dioxygenaseIndirectly related to phytol and vitamin E metabolism
CLA1Chloroplast biogenesis proteinAffects chlorophyll and phytol release
NYC1Chlorophyll b reductaseInvolved in chlorophyll degradation and phytol release
PPHPheophytinase, removes phytol from pheophytinDirectly releases phytol during chlorophyll breakdown

How Is phytol metabolic process Regulated?

Phytol metabolic process is regulated at multiple levels. In plants, the expression of phytol kinase and phytol dehydrogenase genes is induced during senescence and under stress conditions, coordinating phytol release with chlorophyll breakdown. In mammals, phytol metabolism is regulated by dietary intake and by peroxisomal enzyme levels; phytanic acid accumulation can feedback-inhibit alpha-oxidation. Fat-soluble vitamin status, including vitamin K and vitamin E, can influence phytol metabolism because these vitamins share overlapping transport and enzyme systems. Additionally, drug-nutrient interactions may affect the absorption and metabolism of phytol and related lipids. Microbial strain engineering studies have shown that modulating metabolic flux can enhance phytol-derived product formation.

phytol metabolic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
PHYHRefsum diseasePHYH knockout cell line or mouse model
PEX7Refsum disease, peroxisomal biogenesis disorderPEX7 knockout fibroblasts or zebrafish
VKORC1Vitamin K-dependent clotting disordersVKORC1 point-mutation knock-in cells
TTPAAtaxia with vitamin E deficiencyTTPA knockout hepatocytes
PHYKPlant lipid metabolismArabidopsis phyk mutants
Refsum disease and peroxisomal disorders
Refsum disease is an inherited neurological disorder caused by mutations in PHYH or PEX7, leading to phytanic acid accumulation due to defective alpha-oxidation. Patients present with retinitis pigmentosa, peripheral neuropathy, and cerebellar ataxia. Phytol is a dietary precursor of phytanic acid, so restricting phytol intake is a therapeutic strategy. This directly links GO:0033306 to human disease.
Glioma progression and fat-soluble vitamin metabolism
A recent study associated fat-soluble vitamin metabolic processes, including phytol-related pathways, with glioma progression. The findings suggest that dysregulation of these metabolic pathways may contribute to tumor aggressiveness. This highlights the potential of targeting phytol metabolism in neuro-oncology research.
Biomedical activities of phytol
Phytol and its derivatives exhibit antioxidant, anti-inflammatory, and anticancer activities in preclinical models. These effects may be mediated through modulation of oxidative stress and signaling pathways. However, clinical evidence is limited, and further research is needed to translate these findings.
Drug-nutrient interactions
Interactions between drugs and nutrients can affect fat-soluble vitamin and phytol metabolism, potentially altering drug efficacy or toxicity. This is relevant for patients on medications that influence lipid absorption or peroxisomal function.

From phytol metabolic process-Related Genes to Experimental Models

Research QuestionSuitable Model
Does PHYH loss cause phytanic acid accumulation?PHYH knockout human cell line (e.g., HEK293)
What is the effect of a specific PHYH point mutation on enzyme activity?PHYH point-mutation knock-in cells
Can phytol metabolism be redirected to produce vitamin E?Overexpression of VTE1 in plant or microbial cells
How does phytol affect oxidative stress in neurons?PHYH knockout neurons treated with phytol
Does phytol metabolism influence glioma cell proliferation?Glioma cell lines with CRISPR knockout of PHYH or PEX7
Can microbial strains be engineered to upgrade phytol conversion?Overexpression of phytol kinase and dehydrogenase in yeast

How to Study the phytol metabolic process Process

MethodWhat It MeasuresTypical Application
LC-MS/MS lipidomicsPhytol, phytanic acid, and intermediatesQuantifying pathway flux in cells and tissues
Enzyme activity assayPhytol kinase or PHYH activityCharacterizing mutant enzymes
CRISPR knockout screenGenes affecting phytol sensitivityDiscovering novel pathway regulators
roGFP2-Orp1 biosensorIntracellular H2O2 dynamicsMonitoring oxidative stress during phytol treatment
RNA-seqTranscriptional changes in phytol metabolism genesStudying regulation under stress or disease
Western blotProtein expression of PHYH, PEX7, etc.Validating knockout or overexpression models
Gas chromatographyPhytol and phytanic acid levelsClinical diagnosis of Refsum disease
Microbial fermentationPhytol conversion to value-added productsStrain engineering for industrial applications
Metabolomics and lipidomics
Mass spectrometry-based metabolomics and lipidomics are used to quantify phytol, phytanic acid, and intermediates in cells and tissues. These methods are essential for assessing pathway flux and diagnosing peroxisomal disorders.
Enzyme activity assays
In vitro enzyme assays measure the activity of phytol kinase, phytol dehydrogenase, and phytanoyl-CoA hydroxylase using recombinant proteins or cell lysates. These assays help determine the impact of mutations on enzyme function.
CRISPR-based genetic screens
CRISPR knockout screens can identify genes required for phytol metabolism and resistance to phytol-induced toxicity. Such screens are useful for discovering novel regulators of the pathway.
Fluorescent biosensors for oxidative stress
Genetically encoded sensors such as roGFP2-Orp1 can monitor H2O2 dynamics during phytol-induced oxidative stress in plant and mammalian cells. This approach links phytol metabolism to redox biology.

How CRISPR Can Be Used to Study GO:0033306 phytol metabolic process

Knockout

CRISPR knockout of PHYH or PEX7 in human cell lines can model Refsum disease by causing phytanic acid accumulation. Knockout of phytol kinase in plants or microbes can block phytol activation and reveal downstream effects. These models are valuable for studying loss-of-function phenotypes.

Point Mutation

Introducing patient-specific point mutations in PHYH or PEX7 via CRISPR base editing or homology-directed repair allows researchers to study the functional impact of individual variants. This approach is useful for genotype-phenotype correlation in peroxisomal disorders.

Knock-in

Knock-in of tagged versions of PHYH or phytol kinase enables live-cell imaging and proteomic analysis of the enzymes. Tagged knock-in models can also be used to track subcellular localization in peroxisomes or chloroplasts.

Overexpression

CRISPR activation or cDNA overexpression of phytol kinase and phytol dehydrogenase can enhance phytol metabolism in microbial or plant systems. Overexpression models are used to study pathway flux and to engineer strains for industrial production of phytol-derived compounds.

How EDITGENE Supports phytol metabolic process Research

Researchers studying phytol metabolic process-related genes often need to determine whether a candidate gene is causally involved in the pathway, how mutations affect enzyme function, and whether modulating the gene alters disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for phytol metabolic process research.

Frequently Asked Questions About phytol metabolic process

GO:0033306 is a Gene Ontology biological process term defined as the chemical reactions and pathways involving phytol, (2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol.
Key genes include PHYH, PHYK, ADH, ALDH, PEX7, and VKORC1, among others.
Phytol is a branched-chain unsaturated fatty alcohol that is a component of chlorophyll and is released during chlorophyll breakdown.
Phytol is oxidized to phytanic acid, which then undergoes alpha-oxidation in peroxisomes, a process requiring PHYH.
Refsum disease is caused by defects in phytanic acid alpha-oxidation, and fat-soluble vitamin metabolic processes including phytol pathways have been associated with glioma progression.
PHYH encodes phytanoyl-CoA hydroxylase, which catalyzes the first step of alpha-oxidation of phytanic acid; mutations cause Refsum disease.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study gene function in phytol metabolism.
Phytol exhibits antioxidant, anti-inflammatory, and anticancer activities in preclinical studies.
Methods include LC-MS/MS lipidomics, enzyme activity assays, and fluorescent biosensors for oxidative stress.
In plants, phytol metabolism is essential for recycling chlorophyll-derived lipids and for producing phytanic acid and vitamin E precursors.

Conclusion

GO:0033306 phytol metabolic process is a biologically and clinically significant pathway that spans plant lipid remodeling, human peroxisomal disease, and pharmacological research. The pathway involves the release of phytol from chlorophyll, its phosphorylation and oxidation, and its conversion to phytanic acid, which requires alpha-oxidation. Dysregulation of this process is linked to Refsum disease and has been associated with glioma progression. Phytol and its derivatives also show promising biomedical activities. Understanding the genes and mechanisms of phytol metabolism provides a foundation for therapeutic development and for engineering microbial and plant systems. Continued research using CRISPR models and advanced metabolomics will further elucidate this pathway.

References

  1. 1. Shearer MJ. 1995. Vitamin K.. Lancet 345(8944):229-34 PMID: 7823718
  2. 2. Gutbrod K et al.. 2019. Phytol metabolism in plants.. Prog Lipid Res 74:1-17 PMID: 30629961
  3. 3. Nietzel T et al.. 2019. The fluorescent protein sensor roGFP2-Orp1 monitors in vivo H(2) O(2) and thiol redox integration and elucidates intracellular H(2) O(2) dynamics during elicitor-induced oxidative burst in Arabidopsis.. New Phytol 221(3):1649-1664 PMID: 30347449
  4. 4. AMES SR. 1958. Fat-soluble vitamins.. Annu Rev Biochem 27(3):371-402 PMID: 13571938
  5. 5. Zhou W et al.. 2022. [Upgrading microbial strains for fermentation industry].. Sheng Wu Gong Cheng Xue Bao 38(11):4200-4218 PMID: 37699686
  6. 6. Wada M. 2012. [Interactions of drug and nutrient].. Nihon Rinsho 70 Suppl 6:316-24 PMID: 23156527
  7. 7. Islam MT et al.. 2018. Phytol: A review of biomedical activities.. Food Chem Toxicol 121:82-94 PMID: 30130593
  8. 8. Sasaki Y et al.. 2024. Association between Fat-Soluble Vitamin Metabolic Process and Glioma Progression.. Biol Pharm Bull 47(10):1682-1689 PMID: 39443086
Contact Us
*
*
*
*
How did you hear about us: